These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38675214)

  • 21. Development of Ternary Amorphous Solid Dispersions Manufactured by Hot-Melt Extrusion and Spray-Drying─Comparison of
    Trenkenschuh E; Blattner SM; Hirsh D; Hoffmann R; Luebbert C; Schaefer K
    Mol Pharm; 2024 Mar; 21(3):1309-1320. PubMed ID: 38345459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes: Comparison between 3D Printing and Hot-Melt Extrusion Technologies.
    Zhang J; Lu A; Thakkar R; Zhang Y; Maniruzzaman M
    Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving drug release rate, drug-polymer miscibility, printability and processability of FDM 3D-printed tablets by weak acid-base interaction.
    Patel NG; Serajuddin ATM
    Int J Pharm; 2023 Feb; 632():122542. PubMed ID: 36566823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comparative Assessment of Cocrystal and Amorphous Solid Dispersion Printlets Developed by Hot Melt Extrusion Paired Fused Deposition Modeling for Dissolution Enhancement and Stability of Ibuprofen.
    Mandati P; Nyavanandi D; Narala S; Alzahrani A; Vemula SK; Repka MA
    AAPS PharmSciTech; 2023 Oct; 24(7):203. PubMed ID: 37783961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of multifunctional drug delivery system via hot-melt extrusion paired with fused deposition modeling 3D printing techniques.
    Zhang Z; Feng S; Almotairy A; Bandari S; Repka MA
    Eur J Pharm Biopharm; 2023 Feb; 183():102-111. PubMed ID: 36632906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
    Gültekin HE; Tort S; Acartürk F
    Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide.
    Pistone M; Racaniello GF; Arduino I; Laquintana V; Lopalco A; Cutrignelli A; Rizzi R; Franco M; Lopedota A; Denora N
    Drug Deliv Transl Res; 2022 Aug; 12(8):1895-1910. PubMed ID: 35138629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of porosity on drug release kinetics of swellable and erodible porous pharmaceutical solid dosage forms fabricated by hot melt droplet deposition 3D printing.
    Zhang B; Nasereddin J; McDonagh T; von Zeppelin D; Gleadall A; Alqahtani F; Bibb R; Belton P; Qi S
    Int J Pharm; 2021 Jul; 604():120626. PubMed ID: 33957266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Gastroretentive Floating Pulsatile Drug Delivery System Produced via Hot-Melt Extrusion and Fused Deposition Modeling 3D Printing.
    Reddy Dumpa N; Bandari S; A Repka M
    Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31936212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
    Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
    Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QbD guided development of immediate release FDM-3D printed tablets with customizable API doses.
    Crișan AG; Iurian S; Porfire A; Rus LM; Bogdan C; Casian T; Lucacel RC; Turza A; Porav S; Tomuță I
    Int J Pharm; 2022 Feb; 613():121411. PubMed ID: 34954001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials-Process Perspective.
    Azad MA; Olawuni D; Kimbell G; Badruddoza AZM; Hossain MS; Sultana T
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hot-Melt 3D Extrusion for the Fabrication of Customizable Modified-Release Solid Dosage Forms.
    Lee J; Song C; Noh I; Song S; Rhee YS
    Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32764499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.
    Obeid S; Madžarević M; Ibrić S
    Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation.
    Zhang J; Yang W; Vo AQ; Feng X; Ye X; Kim DW; Repka MA
    Carbohydr Polym; 2017 Dec; 177():49-57. PubMed ID: 28962795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Veering to a Continuous Platform of Fused Deposition Modeling Based 3D Printing for Pharmaceutical Dosage Forms: Understanding the Effect of Layer Orientation on Formulation Performance.
    Kulkarni VR; Chakka J; Alkadi F; Maniruzzaman M
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms.
    Ayyoubi S; Cerda JR; Fernández-García R; Knief P; Lalatsa A; Healy AM; Serrano DR
    Int J Pharm; 2021 Mar; 597():120336. PubMed ID: 33545280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Incorporation into Polymer Filament Using Simple Soaking Method for Tablet Preparation Using Fused Deposition Modeling.
    Tagami T; Kuwata E; Sakai N; Ozeki T
    Biol Pharm Bull; 2019; 42(10):1753-1760. PubMed ID: 31582663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced Supersaturation via Fusion-Assisted Amorphization during FDM 3D Printing of Crystalline Poorly Soluble Drug Loaded Filaments.
    Buyukgoz GG; Kossor CG; Davé RN
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.